Delivery Order SPE2DB20D2104-SPE2DB24FMAYV

Award Date 9/6/24
Potential Completion Date 9/9/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,528.37 delivery order contract is for the supply of Clonidine HCL ER 0.1 mg tablets to support military healthcare programs. The contract has a firm fixed price pricing type and an ultimate completion date of January 27, 2025. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,912.42, is for the delivery of Clonidine HCL ER 0.1 mg tablets in 60-count packages. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical division. This IDC serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,101.24 delivery order contract is for the supply of Clonidine HCL ER 0.1 mg tablets. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clonidine HCL ER 0.17 MG Tablets in 30-count packages, with a ceiling value of $1,081.95 and a period of performance through April 16, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,810.82 firm fixed price delivery order is for the supply of 4564147411 - Clonidine HCL ER 0.1 mg Tablets, 60s. This award is a child order under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary...
This federal contract award, valued at $1,270.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of clonidine HCL ER 0.1 mg tablets in 60-count packages, with a completion date of November 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,195.84 firm fixed-price delivery order is for the supply of CLONIDINE HCL ER 0.1 MG TABLET 60S, a medication used to treat high blood pressure and other medical conditions. The contract has an ultimate completion date of March 26, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,460.48 firm-fixed-price delivery order is for the supply of 4565250057 - Clonidine HCL ER 0.1 mg Tablets, with a period of performance through July 26, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,660.23, is for the delivery of Clonidine HCL ER 0.1 mg tablets in quantities of 60s. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,840.10, is for the delivery of CLONIDINE HCL ER 0.1 MG TABLET 60S. This is a firm fixed-price delivery order contract with an ultimate completion date of November 24, 2023. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FMAYV
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,238.72 firm fixed-price delivery order is for the supply of Clonidine HCL ER 0.1 mg tablets, with a completion date of September 9, 2024.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 1:26 PM